Ann: Meluka Honey US Update, page-32

Should there have been a change in substantial holding announcement from the huge volume days 12MAR (33.5m) and 28MAR (25.3m) or with the 58m placement @.06 and free oppies issued on 26MAR. Have they just been selling them on market and keeping the oppies?

The placement which was completed at a premium to the current share price will provide additional working capital to the Company, including the Meluka Health divisions, of which EVE has recently moved to 100% control (see release 25 February 2019). $250,000 of the shares were issued to substantial strategic shareholder TRT Investment Group (“TRT”). TRT is the Australian subsidiary of Tianjin Tongrentang Group one of China’s oldest pharmaceutical and traditional chinese medicine (TCM) enterprises and has a well-developed, extensive distribution network throughout China.

Does anyone have access to the broker reports for the last month or since January?? TIA.